Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Syncromune
AddedFeb 17, 2024
UpdatedJun 18, 2026
Syncromune

Syncromune

Seed

Syncromune™: A leading clinical-stage biopharma firm innovating immunotherapies for metastatic cancers.

HQ
Fort Lauderdale, FL, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Syncromune is a clinical-stage biopharmaceutical company focused on developing advanced immunotherapies for metastatic solid tumor cancers. The company is pioneering combination immunotherapies, which are considered the future of cancer treatment. Their flagship product, SYNC-T™, is a personalized in situ combination multi-target cancer therapy that combines partial oncolysis of a tumor with the infusion of a multi-target biologic drug directly into the tumor, aiming to enhance the immune system's ability to recognize and attack cancer.

Syncromune has made significant strides in the field of cancer immunotherapy, positioning itself as a leader in innovative cancer treatments. The company's approach has garnered attention from thought leaders in oncology, highlighting its potential impact on future cancer therapies. Syncromune's dedication to advancing personalized medicine is reflected in its cutting-edge research and development efforts, contributing to the broader goal of improving outcomes for patients with metastatic cancers.

Syncromune - Similar Companies

INmune Bio logo

INmune Bio

inmunebio.com

Immunome logo

Immunome

Synchronicity Pharma logo

Synchronicity Pharma

Umoja Biopharma logo

Umoja Biopharma

Duet BioTherapeutics logo

Duet BioTherapeutics

Surge Therapeutics logo

Surge Therapeutics

surgetx.com

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

Imvaq Therapeutics logo

Imvaq Therapeutics

Photonpharma logo

Photonpharma

photonpharma.net

ImmunityBio logo

ImmunityBio

immunitybio.com

Fuse Biotherapeutics logo

Fuse Biotherapeutics

fusebiotx.com

Inimmune logo

Inimmune

inimmune.com

Iovance Biotherapeutics logo

Iovance Biotherapeutics

iovance.com

ImmunoMet Therapeutics logo

ImmunoMet Therapeutics

immunomet.com

Symphony Biosciences logo

Symphony Biosciences

Syncromune - Quick Facts

Who are Syncromune's competitors?

Companies similar to Syncromune include INmune Bio, Immunome, Synchronicity Pharma and Umoja Biopharma.

When was Syncromune founded?

Syncromune was founded in 2020.

Where is Syncromune's headquarters located?

Syncromune's headquarters is located in Fort Lauderdale, FL, US.

When was Syncromune's last funding round?

Syncromune's most recent funding round was for $10M (USD) in April 2021.

How much has Syncromune raised to-date?

As of Apr 1, 2021, Syncromune has raised a total of $10M (USD).

How many employees does Syncromune have?

Syncromune has 30 employees as of Feb 5, 2024.

Syncromune - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Therapy
  • Immunotherapy
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified